Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Utilization of bcs based biowaivers for approval of drug products: current practice

  • At: 2014 FIP Congress in Bangkok (Thailand)
  • Type: Poster
  • By: DRESSMAN, Jennifer (Goethe University, Pharmaceutical Technology, Frankfurt am main, Germany)
  • Abstract:

    Background information: The biowaiver procedure based on the Biopharmaceutical Classification System (BCS) utilizes dissolution testing as a tool for bioequivalence evaluation instead of in vivo pharmacokinetic studies. Thus, the BCS-based biowaiver procedure helps to reduce the cost and improve the availability of generic products.
    Aim: This..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses